Foundations in Continuing Education

The Dental Patient with Diabetes

Chapter Three - Diabetes Mellitus Type 1


Chapter 1: Glucose Metabolism and Hormonal Regulation Review

Chapter 2: Diabetes Mellitus

Etiology
Pathophysiology
Epidemiology

Chapter 4: Diabetes Mellitus Type 2

Chapter 5: Gestational Diabetes Mellitus (GDM)

Chapter 6: Pre Diabetes: Impaired Glucose Homeostasis

Chapter 7: Other Specific Types of Diabetes

Chapter 8: Diagnosing Diabetes

Chapter 9: Diagnosis

Chapter 10: Glucose Monitoring

Chapter 11: Complications of Diabetes

Chapter 12: The Dental Patient with Diabetes

Chapter 13: Successful Intervention of Diabetic Emergencies

Chapter 14: Prevention and Treatment of DM

Chapter 15: Diabetes Medications

Chapter 16: Conclusion

Glossary

Appendices

References

Post Examination

Exit to Menu





Etiology

The absence of insulin characterizes Type 1. Individuals with Type 1 must take insulin shots to live. The etiology of Type 1 is a combination of genetic and environmental factors. Recently, Type 1 was divided into two categories, (a) immune-mediated diabetes (resulting from an autoimmune destruction of ß-cells) and (b) idiopathic diabetes (rare forms without a known cause). (5)

Autoimmune Destruction

Individuals diagnosed with Type 1, show signs of pancreatic ß-cell destruction prior to diagnosis. Autoantibodies, which destroy pancreatic cells, may be present up to nine years before a diagnosis of Type 1. The rate of ß-cell destruction is highly variable. Hyperglycemia would indicate that enough destruction of ß-cells had taken place as to prevent adequate insulin secretion.

The presence of one or more of the following is (are) considered predictor(s) of Type 1 onset:

  • islet cell autoantibodies (ICAs),
  • insulin autoantibodies (IAAs),
  • autoantibodies to the enzyme glutamic acid decarboxylase (GAD) and
  • autoantibodies to tyrosine phosphatases IA-2 and IA-2beta

Dr. Mark Atkinson, University of Florida and Dr. Daniel Kaufman, University of California Los Angeles, suggest that autoimmune destruction of GAD is the first phase in the subsequent destruction of ß-cells. These researchers successfully prevented the destruction of ß-cells by inactivating the autoimmune response to GAD. (3,8,11,17,18)

Idiopathic Diabetes

Individuals who have no evidence of an autoimmune disorder, but present with destroyed ß-cells are identified as having "idiopathic diabetes". This form of Type 1 is considered rare. (18)

Continue on to Pathophysiology